U.S. Markets open in 3 hrs 41 mins

Ligand Pharmaceuticals Incorporated (LGND)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
113.3800-0.44 (-0.39%)
At close: 4:00PM EDT
People also watch
NBIXINCYVICLALKSPGNX
Interactive chart
Previous Close113.8200
Open113.8300
Bid92.0000 x 100
Ask0.0000 x
Day's Range113.3300 - 114.8400
52 Week Range87.5000 - 139.7900
Volume161,323
Avg. Volume242,172
Market Cap2.38B
Beta1.08
PE Ratio (TTM)-745.92
EPS (TTM)-0.15
Earnings DateAug 2, 2017 - Aug 7, 2017
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2010-07-02
1y Target Est132.50
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETFs with exposure to Ligand Pharmaceuticals, Inc. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ligand Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to LGND-US. Comparing the performance and risk of Ligand Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Business Wire3 days ago

    Ligand to Participate in Two Upcoming Investor Conferences

    Ligand Pharmaceuticals Incorporated announces that company executives are scheduled to participate in the following upcoming investor conferences:

  • Ligand Pharmaceuticals, Inc. :LGND-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017
    Capital Cube6 days ago

    Ligand Pharmaceuticals, Inc. :LGND-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017

    Categories: Yahoo FinanceGet free summary analysis Ligand Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Ligand Pharmaceuticals, Inc. – Amgen Inc., GTx, Inc., Spectrum Pharmaceuticals, Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Baxter International Inc., Pfizer Inc., GlaxoSmithKline ... Read more (Read more...)